Investor Presentation Full Year 2017
Investor Presentation
Full year 2017
Slide 107
Stable ownership structure
-
secured through A and B-share structure
Share structure
Novo Nordisk Foundation
Novo Holdings A/S
76.1% of votes
28.1% of capital
Institutional and private
investors
23.9% of votes
71.9% of capital
The Novo Nordisk Foundation
The Novo Nordisk Foundation is a self-governing institution
that:
• provides a stable basis for Novo Nordisk
•
supports scientific, humanitarian and social purposes
• All strategic and operational matters are governed by the
board and management of Novo Nordisk
.
Overlapping board memberships ensure that the Novo
Nordisk Foundation and Novo Nordisk share vision and
strategy
A shares
537m shares
B shares
1,963m shares
Novo Nordisk A/S
Note: Treasury shares are included in the capital but have no voting rights
changing
diabetes
novo nordiskView entire presentation